Patents by Inventor Jamal Mustafa

Jamal Mustafa has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11588068
    Abstract: A photo detector having a substrate and a first structure formed on the substrate. The first structure includes an emitter layer formed on the substrate and a base layer formed on the emitter layer. Further, the first structure includes a collector layer formed on the base layer. The collector layer has a plasmonic structure. The plasmonic structure includes a first plurality of mesa structures. Each of the mesa structures of the first plurality of mesa structures includes a second plurality of mesa structures having ridges arranged in a regularly repeating pattern.
    Type: Grant
    Filed: November 20, 2020
    Date of Patent: February 21, 2023
    Assignee: RAYTHEON COMPANY
    Inventors: Jamal Mustafa, Edward P. Smith, Bradly Eachus
  • Publication number: 20220165903
    Abstract: A photo detector having a substrate and a first structure formed on the substrate. The first structure includes an emitter layer formed on the substrate and a base layer formed on the emitter layer. Further, the first structure includes a collector layer formed on the base layer. The collector layer has a plasmonic structure. The plasmonic structure includes a first plurality of mesa structures. Each of the mesa structures of the first plurality of mesa structures includes a second plurality of mesa structures having ridges arranged in a regularly repeating pattern.
    Type: Application
    Filed: November 20, 2020
    Publication date: May 26, 2022
    Applicant: Raytheon Company
    Inventors: Jamal Mustafa, Edward P. Smith, Bradly Eachus
  • Patent number: 10890492
    Abstract: A bolometer pixel trigger array includes a substrate, an electrically conductive contact pad formed on the substrate, and bolometer formed on the substrate. The bolometer includes at least one thermally conductive trigger arm having a fixed end coupled to a portion of the bolometer and an electrically conductive free end configured to deflect with respect to the fixed end. At least one trigger arm establishes different operating states of the bolometer pixel trigger in response to the at least one trigger arm realizing different temperatures. The different operating states are configured to change an electrical connection between the at least one trigger arm and the contact pad.
    Type: Grant
    Filed: June 12, 2019
    Date of Patent: January 12, 2021
    Assignee: RAYTHEON COMPANY
    Inventors: Matthew Thomas, Craig R. Adams, Ryan Boesch, Jamal Mustafa
  • Publication number: 20200393304
    Abstract: A bolometer pixel trigger array includes a substrate, an electrically conductive contact pad formed on the substrate, and bolometer formed on the substrate. The bolometer includes at least one thermally conductive trigger arm having a fixed end coupled to a portion of the bolometer and an electrically conductive free end configured to deflect with respect to the fixed end. At least one trigger arm establishes different operating states of the bolometer pixel trigger in response to the at least one trigger arm realizing different temperatures. The different operating states are configured to change an electrical connection between the at least one trigger arm and the contact pad.
    Type: Application
    Filed: June 12, 2019
    Publication date: December 17, 2020
    Inventors: Matthew Thomas, Craig R. Adams, Ryan Boesch, Jamal Mustafa
  • Publication number: 20020072505
    Abstract: Methods and compositions for treating airway diseases such as asthma and inflammation are described. The methods utilize the concurrent administration of an A3 adenosine receptor antagonist and an A2B adenosine receptor antagonist (either separately or put together chemically in a single molecule having both A3 and A2B blocking effect), for both receptor binding agents and antisense oligonucleotides. The compositions contain both an A3 adenosine receptor antagonist and an A2B adenosine receptor antagonist, together in a pharmaceutically acceptable carrier.
    Type: Application
    Filed: November 30, 2001
    Publication date: June 13, 2002
    Inventor: S. Jamal Mustafa
  • Patent number: 6387913
    Abstract: Methods and compositions for treating airway diseases such as asthma and inflammation are described. The methods utilize the concurrent administration of an A3 adenosine receptor antagonist and an A2B adenosine receptor antagonist (either separately or put together chemically in a single molecule having both A3 and A2B blocking effect), for both receptor binding agents and antisense oligonucleotides. The compositions contain both an A3 adenosine receptor antagonist and an A2B adenosine receptor antagonist, together in a pharmaceutically acceptable carrier.
    Type: Grant
    Filed: November 30, 2001
    Date of Patent: May 14, 2002
    Inventor: S. Jamal Mustafa
  • Patent number: 6022172
    Abstract: The present invention relates to portable flexible fillable barriers that are used to restrain the flow of fluids and to serve as reservoirs, containers (for solids as well) and embankments. The portable flexible fillable barrier is collapsible upon itself into a smaller size, facilitating storage and transportation, and is self-opening from the collapsed state. The portable flexible fillable barrier has a flexible fillable wall comprising an upper portion, a lower portion, a top end, a bottom end, several sides, a number of openings and a supporting frame that has inner structural cells with cell openings and an enclosing flexible membrane. Numerous portable flexible fillable barriers may share a fluid path formed by holes in shared side walls or formed by tubes leading from one portable flexible fillable barrier to another.
    Type: Grant
    Filed: July 8, 1997
    Date of Patent: February 8, 2000
    Inventor: Jamal Mustafa Siyaj
  • Patent number: 5932557
    Abstract: Preclinical studies in mice and rats based on three microinfusions (12 hours apart) of specifically designed and synthesized adenosine A.sub.1 receptor antisense oligonucleotide with the sequence: (A.sub.1 Antisense: 5'-GGCCGAGATGGAGGGCGGCAT-3' (SEQ ID NO: 1)) and as a control, a mismatched antisense nucleotide with a sequence: (A.sub.1 Sense: 5'-ATGCCGCCCTCCATCTCGGCC-3' (SEQ ID NO: 1)) established that the "functional knock out" of A.sub.1 receptors protected the animals from the well known motor incoordination due to alcohol or .DELTA..sup.9 -tetrahydrocarnabinol(THC: the major psychoactive component of marijuana intake). The motor coordination in animals was evaluated by the mouse/rat rotorod treadmill. The antisense was microinfused in mouse cerebellum and in the rat motor cortex whereas ethanol was always administered systemically. However, unlike ethanol, the .DELTA..sup.9 -THC was microinfused into the mouse cerebellum following the cerebellar pretreatment with the antisense.
    Type: Grant
    Filed: August 12, 1997
    Date of Patent: August 3, 1999
    Inventors: S. Jamal Mustafa, M. Saeed Dar